The first symptom of myelofibrosis is usually fatigue, reported by 84% of patients at the time of diagnosis. Many people also notice a feeling of fullness or discomfort on the left side of the abdomen, drenching night sweats, or unexplained weight loss. Up to 21% of patients have no symptoms at all when they’re diagnosed, with the disease discovered only through a routine blood test showing anemia or an enlarged spleen found during a physical exam.
Myelofibrosis is a rare bone marrow disorder, diagnosed in roughly 0.49 per 100,000 people per year, with a median age at diagnosis of 67. Because the symptoms overlap with so many other conditions, and because they often develop gradually, it helps to understand what to look for and why these particular symptoms arise.
Fatigue and Weakness
Fatigue is by far the most common early symptom. It’s not ordinary tiredness that improves with rest. Patients describe a deep, persistent exhaustion that interferes with daily activities and doesn’t match their level of physical effort. This happens because the bone marrow, which normally produces red blood cells, is gradually being replaced by scar tissue. The resulting drop in red blood cells (anemia) starves tissues of oxygen, leaving you feeling drained and short of breath during activities that used to feel easy.
Anemia is so central to myelofibrosis that a hemoglobin level below 10 g/dL is one of the key factors doctors use to assess how serious the disease is. Some people first learn something is wrong when a routine blood panel comes back with low red blood cell counts.
Abdominal Discomfort and Early Fullness
The second hallmark of early myelofibrosis is discomfort in the upper left abdomen, caused by an enlarged spleen. When the bone marrow can’t produce blood cells efficiently, the spleen picks up the slack, filtering and manufacturing cells on its own. This extra workload causes it to swell, sometimes dramatically. In one study, 74% of patients with an enlarged spleen had it extending 10 to 20 centimeters below the rib cage, and 4% had it grow even larger.
An enlarged spleen presses on surrounding organs, especially the stomach. This creates a feeling of fullness after eating only a small amount of food, a symptom called early satiety. Among patients with spleen enlargement, 79% reported early satiety compared to 47% of those without it. Left-sided abdominal pain or discomfort was even more common: 85% of patients with an enlarged spleen reported it, versus 37% of those without. If you find yourself unable to finish meals or feeling pressure under your left ribs, these are symptoms worth mentioning to your doctor.
Night Sweats, Fever, and Weight Loss
Myelofibrosis triggers a cascade of inflammatory signaling molecules in the body. These chemical messengers cause a cluster of whole-body symptoms that doctors call “constitutional symptoms,” and they often appear early in the disease.
Night sweats affect about 56% of patients. These aren’t mild episodes of feeling warm. People with myelofibrosis often wake up drenched, needing to change sheets or clothing. Fever occurs in about 18% of patients, sometimes presenting as a persistent low-grade warmth rather than a sharp spike in temperature. Unintentional weight loss, defined as losing more than 10 pounds in six months without trying, affects about 20% of patients.
Notably, night sweats were significantly more common in patients who also had an enlarged spleen (65%) than in those without one (50%), suggesting these symptoms tend to cluster together as the disease progresses.
Bone Pain and Itching
About 47% of patients experience bone pain, which can appear early and tends to feel like a deep ache rather than sharp, localized pain. It reflects the physical changes happening inside the bone marrow as scar tissue accumulates and crowds out healthy tissue. The pain is most commonly felt in the legs or hips but can occur anywhere.
Itching (pruritus) affects roughly half of patients and can be surprisingly disruptive. It’s caused by the same inflammatory molecules responsible for the night sweats and fevers. Some people notice it worsens after bathing or showering.
Why Symptoms Develop Slowly
Myelofibrosis exists in two stages, and the earliest stage can be subtle enough to go undetected for years. In the pre-fibrotic stage, the bone marrow shows abnormal cell growth but little to no scarring. Patients in this phase may have mild fatigue, modest anemia, or slightly elevated blood counts, but nothing that feels alarming. Median survival in the pre-fibrotic stage is about 14.7 years, compared to 7.2 years once the disease progresses to the overt fibrotic stage.
Progression from the early stage to full-blown fibrosis is not inevitable, and when it does happen, it can take 10 to 20 years. But certain patterns signal a higher risk of faster progression: worsening anemia, dropping platelet counts, and the emergence of constitutional symptoms like night sweats and weight loss. A specific subgroup of early-stage patients with low blood counts across multiple cell lines tends to progress more quickly and carry a worse outlook overall.
What Drives the Disease
Myelofibrosis starts with a genetic mutation in a blood stem cell. In about 60 to 66% of patients, the mutation occurs in a gene called JAK2. Another 12 to 20% carry a mutation in a gene called CALR, and about 5% have a mutation in a gene called MPL. Around 17% of patients test negative for all three, which can make diagnosis more challenging.
These mutations cause certain bone marrow cells, particularly the large cells responsible for making platelets, to grow abnormally and release a flood of inflammatory proteins. One protein in particular acts as the primary driver of scarring: it signals the support cells surrounding blood vessels in the bone marrow to produce collagen and fibrous tissue. Over time, this scar tissue stiffens the marrow and makes it increasingly difficult for the body to produce normal blood cells, pushing that work to the spleen and liver.
How It’s Typically Discovered
Because myelofibrosis develops gradually, diagnosis often happens through one of three routes: an abnormal complete blood count showing anemia or unusual white blood cell numbers, a physical exam revealing an enlarged spleen, or a blood smear showing immature red and white blood cells circulating in the bloodstream (a pattern called leukoerythroblastosis that signals the bone marrow is under stress).
A formal diagnosis requires a bone marrow biopsy to assess the degree of scarring and to look for the characteristic abnormal platelet-producing cells. Genetic testing for JAK2, CALR, and MPL mutations helps confirm the diagnosis. Under current diagnostic standards, doctors need to identify a combination of bone marrow abnormalities, a relevant genetic mutation, and at least one clinical finding such as anemia, an elevated white blood cell count, or an enlarged spleen.
If you’re experiencing a combination of persistent fatigue, unexplained fullness in your abdomen, drenching night sweats, or unintentional weight loss, these symptoms together form a pattern worth investigating with a complete blood count and physical exam as a starting point.